Showing results (41-50 of 153) with videos related to
Sort By:
Pageof 16
Blood|October 12, 2013
How I treat severe combined immunodeficiencyH Bobby Gaspar, Waseem Qasim, E Graham Davies, et al.Age and Ageing|March 30, 2022
Characterising older adults' risk of harm from blood-pressure lowering medications: a sub-analysis from the PRIME studyAhmed Hussain, Khalid Ali, Nikesh Parekh, et al.Scientific Reports|April 22, 2018
Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsetsYara Alenazi, Kamayani Singh, Graham Davies, et al.The International Journal of Pharmacy Practice|July 8, 2011
An evaluation of using multi-source feedback (MSF) among junior hospital pharmacistsJignesh P Patel, Atisha Sharma, David West, et al.Circulation|August 14, 2013
Population pharmacokinetics of enoxaparin during the antenatal periodJignesh P Patel, Bruce Green, Raj K Patel, et al.The Pediatric Infectious Disease Journal|April 12, 2003
Polymerase chain reaction-based diagnosis of infection with Cryptosporidium in children with primary immunodeficienciesJames McLauchlin, Corinne F L Amar, Susana Pedraza-Díaz, et al.Age and Ageing|March 30, 2022
A multi-centre cohort study on healthcare use due to medication-related harm: the role of frailty and polypharmacyJennifer M Stevenson, Nikesh Parekh, Kia-Chong Chua, et al.Intensive Care Medicine|June 16, 2004
Use of oral clonidine for sedation in ventilated paediatric intensive care patientsSara Arenas-López, Shelley Riphagen, Shane M Tibby, et al.Transplantation|September 29, 2015
Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant RecipientsEsther Gathogo, Mark Harber, Sanjay Bhagani, et al.Communications Biology|April 3, 2025
Development of chemokine network inhibitors using combinatorial saturation mutagenesisJhanna Kryukova, Serena Vales, Megan Payne, et al.Pageof 16